- AU$8.30m
- AU$24.26m
- AU$9.31m
Brief: Cann Group Posts FY Net Loss Attributable Of A$51.2 Million
Brief: Cann Group Posts FY Sales Revenue Of A$15.38M
Brief: Cann Group Appoints Jenni Pilcher As CEO & Managing Director
Brief: Cann Group Reduces Permanent Staff Numbers By More Than 10%
Brief: Cann Group Obtains A$5M Secured Debt Facility
Brief: Cann Group Says Sales Revenue Year To Date Of A$11.6 MLN, Increase Of 18% Over PCP
Brief: Cann Group Receives A$1.9M Payment For Southern Facility Assets
Brief: Cann Group Says Resignation Of CEO Peter Koetsier
Brief: Cann Group Executes Sale & Purchase Agreement For A$1.7 Mln
Brief: Cann Group Posts HY Revenues From Ordinary Activities Up 45.8% To A$8.5 Million
Brief: Cann Group Says To Defend Legal Proceedings Brought By Rua Biosciences
Brief: Rua Bioscience Commences Legal Proceedings Against Cann Group
Brief: Cann Group Posts Qtrly Revenue A$4.46 Mln
Brief: Cann Says Appointment Of Chief Financial Officer/Company Secretary
Brief: Rua Bioscience Says There Have Been Recent Quality Issues With Cann's Export Products
Brief: Cann Group Says CFO Deborah Ambrosini Has Resigned
Australia's Cann Group eyes best day ever on $1.3 mln fund raise
Brief: Cann Group Raises A$2 Million Via Entry Into Convertible Securities Facility
Brief: Cann Group Seeks Trading Halt